With rigorous, evolving, and heterogeneous payer evaluation criteria, challenging price negotiations, and a dynamic competitive environment, manufacturers need to prepare their market access strategy early in the product life cycle and assess often to ensure optimal access. Evidera is ideally positioned to help you create evidence-optimized value strategies to achieve your product access, price and reimbursement goals. Our team brings a deep understanding of payer policy and processes, close payer relationships, and a comprehensive understanding of the key evidence that shapes payer decision making.
Evidera are an official sponsor of Pharma Pricing & Market Access Congress 2018, taking place 20-21 March at the Business Design Centre, London. There are still a few tickets available, so BOOK NOW to join 400+ pharma pricing, market access, evidence professionals.